Beaumont Carole, Delaby Constance
INSERM U773, Centre de Recherche Biomédicale Bichat Beaujon, Université Paris Diderot Paris, UFR de Médecine site Bichat, Paris, France.
Semin Hematol. 2009 Oct;46(4):328-38. doi: 10.1053/j.seminhematol.2009.06.004.
Important advances in our understanding of iron metabolism have been made during the past 10 years, highlighting the mechanisms by which dysregulated iron homeostasis leads to hematologic, metabolic, and neurodegenerative diseases. In particular, the discovery of hepcidin and its fundamental role as the hormonal peptide regulating iron metabolism has delineated the organization of the complex network of proteins that regulates iron metabolism within the body. Maintenance of iron homeostasis is the consequence of tight coordination between iron absorption from the diet by enterocytes, and iron recycling by macrophages following degradation of senescent erythrocytes. Thus, any perturbation of these processes leads to a wide spectrum of diseases, ranging from iron deficiency anemia to iron overload. This review will focus particularly on the mechanisms involved in iron recycling by macrophages and summarize the pathological conditions perturbing this process.
在过去十年中,我们对铁代谢的理解取得了重要进展,突出了铁稳态失调导致血液、代谢和神经退行性疾病的机制。特别是,铁调素的发现及其作为调节铁代谢的激素肽的基本作用,描绘了体内调节铁代谢的复杂蛋白质网络的组成。铁稳态的维持是肠细胞从饮食中吸收铁与巨噬细胞在衰老红细胞降解后进行铁循环之间紧密协调的结果。因此,这些过程中的任何扰动都会导致从缺铁性贫血到铁过载等广泛的疾病。本综述将特别关注巨噬细胞参与铁循环的机制,并总结扰乱这一过程的病理状况。